Dallas, TX, United States of America

Chuo Chen

USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: Innovations by Chuo Chen: Pioneering cGAS Antagonist Compounds

Introduction: Chuo Chen, based in Dallas, TX, is a prolific inventor with an impressive portfolio of 21 patents. His work primarily focuses on groundbreaking compounds that have significant implications in medical therapy, highlighting his role as a key innovator in the field.

Latest Patents: Two of Chuo Chen's latest patents detail Quinoline cGAS antagonist compounds. These patents disclose compounds that act as antagonists to cyclic GMP-AMP synthase (cGAS), along with methods for their preparation, pharmaceutical compositions that incorporate these compounds, and their applications in medical therapy. This contribution is poised to enhance therapeutic options for various medical conditions.

Career Highlights: Chuo Chen's career includes significant tenure with prestigious institutions such as the University of Texas System and Immunesensor Therapeutics, Inc. His work in these organizations has not only fostered his innovative capacity but has also contributed to his extensive body of patents.

Collaborations: Throughout his career, Chuo Chen has collaborated with notable colleagues, including Lijun Sun and Zhijian Chen. These partnerships have enhanced the innovative output of their research efforts and contributed to the advancement of knowledge in their respective fields.

Conclusion: Chuo Chen stands out as a leading inventor whose work on cGAS antagonist compounds demonstrates his commitment to advancing medical science. With a solid foundation in research and collaboration, his contributions continue to pave the way for future innovations in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…